Kalamazoo (WZZM) - Researchers at Metabolic Solutions in Kalamazoo announced the results of a phase two clinical trial.
The drug being studied was originally developed to treat diabetes, but showed potential as a treatment for Alzheimer's disease.
The study looked at the decline in brain glucose metabolism and its link to Alzheimer's.
The drug maintained metabolism levels in key regions of the brain affected by mental decline.
Right now, more than five million Americans live with Alzheimer's disease and as many as 16 million will have it by 2050.
Here in Michigan, in 2010, 180-thousand older adults had Alzheimer's. That's a six percent increase over ten years.
The hope is that this research will lead to new treatments for Alzheimer's.
Doctor Jerry Colca with Metabolic Solutions presented the findings this week at the International Conference on Alzheimer's Drug Discovery.
He talks more about what they found. Click on the video link to watch the segment. Click here to learn more about Metabolic Solutions. Click here to read more about the clinical trial results.